MITO

Stealth BioTherapeutics Corp. ADS

Delisted

MITO was delisted on the 15th of November, 2022.

13 hedge funds and large institutions have $638K invested in Stealth BioTherapeutics Corp. ADS in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
-2
Holders Change %
-13.33%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
5
Reduced
3
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
IC
1
Ikarian Capital
Texas
$350K +$16.2K +23,275 +5%
BBHC
2
Brown Brothers Harriman & Co
New York
$123K
BFM
3
Boothbay Fund Management
New York
$34K
Geode Capital Management
4
Geode Capital Management
Massachusetts
$34K +$17.8K +25,474 +109%
Renaissance Technologies
5
Renaissance Technologies
New York
$33K -$7.39K -10,473 -18%
Millennium Management
6
Millennium Management
New York
$27K -$1.08K -1,542 -4%
Two Sigma Advisers
7
Two Sigma Advisers
New York
$11K -$5.9K -8,800 -35%
Envestnet Asset Management
8
Envestnet Asset Management
Illinois
$10K +$1.27K +1,808 +15%
Osaic Holdings
9
Osaic Holdings
Arizona
$5K +$1.13K +1,482 +29%
Morgan Stanley
10
Morgan Stanley
New York
$4K
Citigroup
11
Citigroup
New York
$4K +$4K +6,000 New
AA
12
AlphaMark Advisors
Kentucky
$2K
UBS Group
13
UBS Group
Switzerland
$1K +$692 +1,092 +224%
GSC
14
Ground Swell Capital
South Carolina
-$16K -18,927 Closed
Citadel Advisors
15
Citadel Advisors
Florida
-$13K -16,213 Closed